Le Lézard
Classified in: Health, Science and technology
Subjects: PARTNERSHIPS, HEALTH

Cassie + Friends and Brain Canada Announce a New Research Partnership to Transform the Mental Health of Youth with Pediatric Rheumatic Disease


VANCOUVER, British Columbia, May 07, 2023 (GLOBE NEWSWIRE) -- Cassie + Friends (C + F) and Brain Canada are pleased to announce their new partnership to fund research that will address mental health in youth with rheumatic diseases such as juvenile arthritis and lupus - conditions that affect every 3 in 1000 kids or 24,000 children across Canada. Together, they want to provide support to children and families living with these painful, chronic, and potentially devastating conditions, and ensure they receive timely care and treatment for their mental health needs.

Pediatric rheumatic diseases can have long-term physical and psychosocial effects on a young person. These conditions can result in chronic pain, fatigue, and physical limitations that can impact the day-to-day and overall quality of life of children and teenagers as well as young adults. Youth with these conditions, and especially females, are at increased risk of developing mental illnesses characterized by alterations in thinking, mood or behaviour associated with significant distress and impaired functioning, such as anxiety and depression.

Jennifer Wilson, Executive Director of Cassie + Friends, says: "Children growing up with rheumatic disease can be severely affected by their diagnosis, symptoms, and treatments. Hearing from youth and their families over the last 16 years just how devastating this can be, with little awareness and few resources to count on, we are thrilled to be leading the way with Brain Canada towards our ultimate vision of a pain-free future for kids that includes relief from mental pain."

A Parent in the C+F community, Jennifer Faber from Windsor, ON, says: "I am so happy to hear about this research funding to help transform mental health for kids like my son, who lives with Juvenile Arthritis. My son was an active 11-year-old when he was diagnosed. His arthritis first disabled him with pain and then crippling anxiety for over a year. He could have really used more emotional support and still could."

Despite the prevalence of co-occurring mental illnesses in pediatric rheumatic diseases, estimated at up to 40 per cent, there is a lack of understanding regarding the factors that contribute to their development, mental health screening for early identification and assessment, as well as limited treatment options to provide timely and appropriate care and support.

With a total funding envelope of $480,000, C+F and Brain Canada are pleased to support two team grants of $240,000 each over two years with an aim to support research that will improve our understanding of the prevention, diagnosis, and treatment of mental illnesses in children and youth.

"We are proud to partner with Cassie + Friends to support this important research initiative," says Dr. Viviane Poupon, President, and CEO of Brain Canada. "This partnership aligns with our commitment to fund innovative research that has the potential to make a real impact on the lives of Canadians living with neurological and mental health conditions."

The call for applications will be announced later this Spring.

For more information about the program and how to apply, please subscribe to receive funding opportunities from Brain Canada: LINK

About Brain Canada
Brain Canada plays a unique and invaluable role as a national convenor of those who support and advance brain research. A greater understanding of how the brain works contributes to the prevention, diagnosis, treatment, and cure of disorders of the brain, ultimately improving the health outcomes of people in Canada and around the world. Visit Braincanada.ca @BrainCanada

About Cassie + Friends
Cassie + Friends' mission is to transform the lives of children and families affected by Juvenile Arthritis and other rheumatic diseases through research, education, connection and support. Our vision is a pain-free future for kids.

Working hand-in-hand with patients, caregivers, healthcare professionals and researchers across every province and territory in Canada, we've created a vibrant, engaged and connected community that helps kids, teens, young adults and their families face the ups and downs of life with a chronic condition ? so that no child has to live in pain alone.

As the only charity in Canada focussed 100% on kids, we've now raised nearly $3.5 million through the help of families, organizations and dedicated friends. Together, we will ensure the 24,000 kids and teens affected by childhood rheumatic disease in Canada - a leading cause of chronic disability in kids - receive the attention, resources and research they deserve. To learn more and join our mission, please visit cassieandfriends.ca.

Media Contact:
Jennifer Wilson
Executive Director
Cassie + Friends
604.617.1382
[email protected] 

Brielle Goulart
Digital Communications & Stewardship Officer
Brain Canada
450-915-2253
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5cef4065-7ffa-4171-bfee-3993c764110a



These press releases may also interest you

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...

at 00:00
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy...

20 mai 2024
Joel's journey to Smile 4 Ever Mexico in Tijuana exemplifies the transformative power of affordable dental care. Struggling with dental problems that affected his quality of life, Joel found a solution in Tijuana, where dental procedures are...



News published on and distributed by: